Osimertinib Dose Escalation Induces Regression of Progressive EGFR T790M-Mutant Leptomeningeal Lung Adenocarcinoma.

Autor: Cordova C; Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, New York, New York., Chi AS; Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, New York, New York. Electronic address: chia01@nyumc.org., Chachoua A; Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, New York, New York., Kondziolka D; Department of Neurosurgery, New York University School of Medicine, New York, New York., Silverman JS; Department of Radiation Oncology, New York University School of Medicine, New York, New York., Shepherd TM; Division of Neuroradiology, Department of Radiology, New York University School of Medicine, New York, New York., Jain R; Division of Neuroradiology, Department of Radiology, New York University School of Medicine, New York, New York., Snuderl M; Division of Molecular Pathology, Department of Pathology, New York University School of Medicine, New York, New York.
Jazyk: angličtina
Zdroj: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2017 Nov; Vol. 12 (11), pp. e188-e190.
DOI: 10.1016/j.jtho.2017.07.029
Databáze: MEDLINE